This technology is a method and computer-accessible medium for determining catheter contact orientation with optical coherence tomography (OCT) for direct visualization of surfaces during radiofrequency ablation (RFA) therapy.
This technology consists of a wearable wrist device that provides continuous blood pressure monitoring that is self-calibrating and utilizes a combination of positional sensors and machine-learning algorithms to adjust for changes in hydrostatic pressure due to arm movement.
This technology, FixR, is a modified peptide and delivery system aimed at reducing pathogenic late sodium currents, which are implicated in cardiac and neurological diseases, including cardiac arrhythmia.
This technology is a small molecule protein therapeutic for systolic heart failure, which improves contractility without an unwanted rise in a patient’s heart rate.
This technology is a pluripotent stem cell derived cardiomyocyte model of early-onset restrictive cardiomyopathy (RCM) based on a mutation in Filamin C (FLNC) which can be harnessed to recapitulate RCM phenotypes and to screen and identify therapeutic compounds for RCM.
This technology is a method of monitoring catheter ablation of faulty electrical pathways in the myocardial tissue of the heart using ultrasound catheter-guided intracardiac echocardiography.
This technology is a hybrid regenerative prosthetic heart valve that can grow with the patient over time, eliminating the need for multiple valve replacement surgeries in pediatric patients.
This technology is a diagnostic tool combining electrocardiography with the power of deep learning algorithms to detect moderate to severe aortic stenosis, aortic regurgitation, and mitral regurgitation.
This technology is a catheter-based optical method for ensuring proper catheter contact with cardiac tissue prior to radiofrequency ablation, in order to improve accuracy for cardiac arrhythmia treatment.